John Schoellerman
Chief Investment Officer en OXFORD NANOPORE TECHNOLOGIES PLC .
Perfil
John Schoellerman is currently the Chairman at Eagle Genomics Ltd.
and the SVP-Corporate Development & Investment at Oxford Nanopore Technologies Plc.
He was previously the Managing Director & Head-Medtech at Lazard Services Holdings Ltd.
He completed his undergraduate degree at Harvard University and earned an MBA from INSEAD.
Cargos activos de John Schoellerman
Empresas | Cargo | Inicio |
---|---|---|
OXFORD NANOPORE TECHNOLOGIES PLC | Chief Investment Officer | 01/01/2019 |
Eagle Genomics Ltd.
Eagle Genomics Ltd. Packaged SoftwareTechnology Services Eagle Genomics Ltd. provides bioinformatics software and services. The firm products include eaglecore and eaglensembl. Its services include NGS data management, analysis, and visualization, and cloud computing for bioinformatics, biomarker discovery, microarray analysis, reproducing methods, and custom software development. The company was founded by Abel Ureta-Vidal in 2008 and is headquartered in Cambridge, the United Kingdom. | Chairman | 29/09/2023 |
Antiguos cargos conocidos de John Schoellerman.
Empresas | Cargo | Fin |
---|---|---|
Lazard Services Holdings Ltd. | Corporate Officer/Principal | - |
Formación de John Schoellerman.
Harvard University | Undergraduate Degree |
INSEAD | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Technology |
Empresas privadas | 2 |
---|---|
Lazard Services Holdings Ltd. | |
Eagle Genomics Ltd.
Eagle Genomics Ltd. Packaged SoftwareTechnology Services Eagle Genomics Ltd. provides bioinformatics software and services. The firm products include eaglecore and eaglensembl. Its services include NGS data management, analysis, and visualization, and cloud computing for bioinformatics, biomarker discovery, microarray analysis, reproducing methods, and custom software development. The company was founded by Abel Ureta-Vidal in 2008 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
- Bolsa de valores
- Insiders
- John Schoellerman